OhioHealth Case Study

OhioHealth Improves Diabetic Retinopathy Testing with LumineticsCore® Autonomous AI

OhioHealth identified a significant care gap in diabetic retinopathy testing rates and sought a solution that would improve diabetes-related eye exam adherence rates, deliver real-time results, and fit seamlessly into primary care workflows. In 2022, OhioHealth partnered with Digital Diagnostics to implement LumineticsCore, the first FDA-cleared autonomous AI to diagnose diabetic retinopathy at the point-of care. Since implementation, OhioHealth has seen significant improvements year over year.